# Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial

> **NCT02256462** · PHASE4 · COMPLETED · sponsor: **Schneider Children's Medical Center, Israel** · enrollment: 82 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT02256462
- **Lead sponsor:** Schneider Children's Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-01
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-01-31
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2021-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02256462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02256462, "Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02256462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*